Global Health Ltd share price logo

Medanta Share Price

(MEDANTA)

Check the latest share price of Medanta, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹1177.8

1.95%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Medanta Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹1,175.8
    Day's Price Range
    ₹1,218
  • 52 Week's Low

    52 Week's High

    ₹935.5
    52-Week Price Range
    ₹1,511
1 Month Return+ 7.61 %
3 Month Return+ 23.99 %
1 Year Return-7.99 %
Previous Close₹1,201.20
Open₹1,205.90
Volume1.47L
Upper Circuit-
Lower Circuit-
Market Cap₹34,109.25Cr

Medanta Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹34,109.25 Cr

Return on Equity (ROE)

13.57

Return on capital employed (ROCE)

16.88

Sector

Healthcare

How to invest in Medanta

Investing in Medanta is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Medanta or MEDANTA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Medanta or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Medanta with just a few clicks!

Medanta Valuation

Track how the P/E of Medanta has moved over time to understand valuation trends.

Medanta in the last 5 years

  • Overview

  • Trends

Lowest (37.92x)

April 6, 2023

Today (60.42x)

December 15, 2023

Industry (104.63x)

December 15, 2023

Highest (65.55x)

December 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 60.42x

Analysts Recommendation on Medanta

Get updated buy, sell, and hold recommendations by analysts on Medanta.

based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

85.71% of analysts recommend a 'BUY' rating for Medanta. Average target of ₹780.14

Source: S&P Global Market Intelligence

Analysts Forecast on Medanta

Get share price movements and forecasts by analysts on Medanta.

Medanta price forecast by 7 analysts

Downside of-38.57%

High

₹840

Target

₹780.14

Low

₹735

Medanta target price ₹780.14, a slight downside of -38.57% compared to current price of ₹1177.8. According to 7 analysts rating.

Source: S&P Global Market Intelligence

Medanta Financials

Get the annual and quarterly financial summary of Medanta, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹779.58Cr (-)₹843.94Cr (↑8.26%)₹836.45Cr (↓0.89%)₹808.63Cr (↓3.33%)₹861.08Cr (↑6.49%)
Net Income₹102.01Cr (-)₹125.16Cr (↑22.69%)₹123.54Cr (↓1.29%)₹127.35Cr (↑3.08%)₹106.26Cr (↓16.56%)
Net Profit Margin13.09% (-)14.83% (↑13.29%)14.77% (↓0.40%)15.75% (↑6.64%)12.34% (↓21.65%)
Value in ₹ crore
Details2019202020212022
Total Assets₹1,757.90Cr (-)₹1,957.90Cr (↑11.38%)₹2,047.10Cr (↑4.56%)₹2,401.86Cr (↑17.33%)
Total Liabilities₹445.97Cr (-)₹535.17Cr (↑20.00%)₹563.46Cr (↑5.29%)₹662.11Cr (↑17.51%)
Value in ₹ crore
Details2019202020212022
Operating Cash Flow₹152.00Cr (-)₹192.56Cr (↑26.68%)₹200.88Cr (↑4.32%)₹235.40Cr (↑17.18%)

Medanta Index Inclusions

BSE 500

₹34,765.79

0 (0%)

S&P BSE 150 MidCap

₹14,959.91

0 (0%)

Nifty 500

₹0.00

0 (0%)

S&P BSE SmallCap Select

₹7,178.77

0 (0%)

BSE Healthcare

₹42,555.65

0 (0%)

Nifty LargeMidcap 250

₹15,416.05

0.1 (15.35%)

BSE Small-Cap

₹48,193.46

0 (0%)

S&P BSE 250 LargeMidCap

₹10,383.27

0 (0%)

S&P BSE 400 MidSmallCap

₹11,171.57

0 (0%)

Nifty Midcap 150

₹20,009.05

0.21 (42.35%)

Nifty MidSmallcap 400

₹18,431.30

0.21 (38.8%)

S&P BSE AllCap

₹10,471.31

0 (0%)

Medanta Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medanta.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
33.08%
0.00
Foreign Institutions
9.89%
0.00
Mutual Funds
9.52%
0.00
Retail Investors
44.68%
0.00
Others
2.83%
0.00

Medanta vs Peers

Compare market cap, revenue, PE, and other key metrics of Medanta with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹34,109.25 Cr41.16%0.59NANA
BUY₹49,038.31 Cr87.36%0.56NANA
BUY₹34,740.31 Cr101.36%0.66NANA

Medanta News & Key Events

Latest news and events at one place to help you take investing decisions in Medanta.

  • Global Health to Establish Hospital in Guwahati - 28 Apr, 2025

    Global Health Ltd, operating under the Medanta brand, announced plans to invest ₹500 crore to develop a 400-bed super specialty hospital in Guwahati, Assam, enhancing healthcare access for over 50 million people in the region.
  • Global Health (Medanta) Positioned for Growth - 11 Apr, 2025

    Global Health (Medanta) is enhancing its brand equity and operational capacity, with a new Noida hospital expected to open in six months. Analysts recommend a buy with a target price of Rs 1,390, citing improvements in ARPOB and revenue drivers.
  • Global Health Files IPO Papers with Sebi - 10 Apr, 2025

    Global Health Limited, owner of the Medanta brand, has filed for an IPO to raise Rs 500 crore. The offering includes a fresh issue and an offer for sale, with major stakeholders offloading shares. Proceeds will be used for debt repayment and corporate purposes.
  • Global Health Secures Land for New Hospital - 08 Apr, 2025

    Global Health Ltd has received a land offer from the Assam Government to establish a super speciality hospital in Guwahati, boosting investor confidence and share prices significantly.
  • Positive Momentum for Global Health Ltd (MEDANTA) - 02 Apr, 2025

    Global Health Ltd (MEDANTA) shows bullish momentum with a recommendation to buy above ₹1,235, targeting ₹1,315-1,345. The stock is rebounding, indicating steady demand and potential for further gains.

Insights on Global Health Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 106.29 Cr → 142.91 Cr (in ₹), with an average increase of 13.6% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 9.00% to 10.36% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, MEDANTA stock has moved up by 15.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 33.03% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 52.4% return, outperforming this stock by 70.0%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 12.47% to 11.76% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 974.77 Cr → 959.46 Cr (in ₹), with an average decrease of 1.6% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 43.98% to 43.28% in Mar 2025 quarter

About Medanta

Global Health Limited (quickly known as GHL) was established on August 13th 2004, and converted to a public limited company on July 31st 2021. It is a renowned private multispeciality tertiary care provider operating in the North and East regions of India, which provides healthcare services in over 30 medical specialties. Dr. Naresh Trehan founded GHL, with current 5 hospitals operational in its network. On November 2009, the company opened its flagship hospital in Gurugram with 200 installed beds and 50 doctors across key specialties, and its Patna hospital currently has 228 installed beds and employs over 125 doctors, designed to accommodate 500 beds. In January 2021, GHL decided to raise capital by
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.

Revenue: ₹861.08Cr as on June 2024 (Q2 24)
Net Profit: ₹106.26Cr as on June 2024 (Q2 24)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
OrganisationMedanta
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

Futures and Options

View the latest movement in Medanta Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Global Health Ltd price today?

Global Health Ltd share price today stands at ₹1177.8, Open: ₹1205.9, Previous Close: ₹1201.2, High: ₹1218, Low: ₹1175.8, 52 Week High: ₹1511, 52 Week Low: ₹935.5.

How to Buy Global Health Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Global Health Ltd shares

What are today's traded volumes of Global Health Ltd?

Today's traded volume of Global Health Ltd(MEDANTA) is 1.47L.

What is today's market capitalisation of Global Health Ltd?

Today's market capitalisation of Global Health Ltd(MEDANTA) is ₹34,109.25 Cr.

What is the 52 Week High and Low Range of Global Health Ltd?

Global Health Ltd (MEDANTA)
Price
52 Week High
₹1511
52 Week Low
₹935.5

How much percentage Global Health Ltd is down from its 52 Week High?

Global Health Ltd (MEDANTA) share price is ₹1177.8. It is down -22.05% from its 52 Week High price of ₹1511

How much percentage Global Health Ltd is up from its 52 Week low?

Global Health Ltd (MEDANTA) share price is ₹1177.8. It is up 25.90% from its 52 Week Low price of ₹935.5